Through our venture fund and Funding Catalyst service, we fuel innovators across Canada and beyond.
.png)
Syantra has been featured in BetaKit ahead of the commercialization of their Onco-ID breast cancer screening test this summer. Syantra will also be releasing updated clinical trial data later in Q2.